Latona Therapeutics Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

Latona Therapeutics General Information


Developer of a drug delivery platform designed to target and eliminate cancerous cells. The company's drug delivery platform is based on light-activated drug releasing nanoparticles to selectively target and treat solid tumors, enabling medical researchers to detect and kill malignant cells painlessly in a cost effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • Chicago, IL
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Latona Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view Latona Therapeutics’s complete valuation and funding history, request access »

Latona Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Lauren Mifflin Co-Founder
Meng-Yang Chen Co-Founder
To view Latona Therapeutics’s complete executive team members history, request access »

Latona Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Polsky Center Accelerator/Incubator 000 0000 000000 0
Matter Accelerator/Incubator Minority 000 0000 000000 0
To view Latona Therapeutics’s complete investors history, request access »